MENU
LPTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Leap Therapeutics (LPTX) Ownership - Who owns Leap Therapeutics?
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.38M
P/E Ratio
N/A
Total Cash
62.82M
Projected Growth
N/A
Total Debt
376K
Revenue
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash/Share
1.52
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LPTX
Capitalization
16.4M
P/E Ratio
N/A
Risk (Beta)
0.87
Dividend Yield
N/A
Total Cash
62.8M
Total Cash/Share
1.52
Total Debt
376K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
49M
P/B Ratio
0.79
Cash Flow
N/A
Earnings
-1.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
38K
Current Ratio
3.97
Current Revenue Per Employee
10416.67
Dividends Per Share - Security
N/A
EBITDA
-64.24M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-87.54
Shares Held By Institutions
40.9M
Shares Outstanding - Current
41.4M
Total Liabilities
16.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-86.435
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in clinical stage immuno-oncology
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com